Heritable factors contribute to nearly all leading causes of disease1
Family history is difficult to quantify and unreliably reported by patients2
Clinically validated genomic insights with actionable recommendations
MyOme provides advanced genomic-informed health screening and diagnostic answers with actionable insights that easily integrate into clinical workflows, allowing providers to deliver personalized care based on each patient's unique needs.
Comprehensive insights
Personalized patient care, from one sample
MyOme's advanced technology sequences the entire genome, offering a comprehensive view of a patient's health risks and actionable clinical insights. This helps providers create data-driven, personalized care plans to promote disease prevention and early detection and support long-term wellness.
Typical clinical risk calculators miss serious disease and estimate 10-year risk, not lifetime
15-25% of all myocardial infarctions will have no clinical risk factors3
30-35% of breast cancer hereditary or familial4
Enhanced screening can be used to detect disease early and improve treatment outcomes:
- Breast MRI
- Coronary CT angiography
- Cancer detection
- https://www.cdc.gov/genomics-and-health/about/index.html
- DOI: 10.1093/jmd/jri174, PMID: 25939339 (DOI: 10.1002/ajmg.a.37139), DOI: 10.18043/ncm.74.4.279
- Mazar J, Figtree G, Vernon ST, Galougahi KK, Carlo J, Nissen SE, et al. Progression of coronary atherosclerosis in patients without standard modifiable risk factors. Am J Prev Cardiol. 2020. Dec 1; 4: 100116. DOI: 10.1016/j.ajpc.2020.100116
- Garber J.E., Offit K. Hereditary Cancer Predisposition Syndromes. J. Clin. Oncol. 2005; 23: 276-292. DOI: 10.1200/JCO.2005.10.042
Our tests
Two ways genomics changes the visit
Genomic-informed screening to help identify personal health risks for conditions such as coronary artery disease and breast cancer, inform medication selection, and guide future screening and treatment decisions.
Atlas tests
Answers for patients who may have a disease with genetic causes, to help identify their condition and create a path forward.
Zenith testsWhat our partners say
Providing these patients and their providers with personalized health insights using MyOme's industry-leading, clinical risk assessments will allow providers to identify potentially life-saving interventions, lifestyle and medication changes, imaging, and early cancer detection tests for their patients.
As we work to overcome long-standing biases in medicine, understanding what we inherit from our parents and ancestors gives us a powerful tool to assess health risks more accurately. Innovative tests from companies like MyOme help provide this crucial knowledge, which empowers patients in their health journey and helps to bring precision medicine to everyone in a fair and effective way.
Privacy
Data protection without compromise
MyOme is committed to patient data privacy. We prioritize data security with uncompromising standards — information is never sold or used without explicit consent. We are HIPAA compliant, encrypt personal data, and regularly update our systems to meet the latest security standards, ensuring maximum data protection.
Privacy and security- HIPAA compliant
- Data encrypted at rest and in transit
- Never sold or shared without explicit consent
Ordering a test
Sign up, collect one sample, get started
Our ordering process is simple: providers sign up through the MyOme Portal and collect just one patient sample to get started.
Sign up
Create an account in the MyOme Portal to order and track tests.
Collect one sample
Blood or buccal — the same sample supports every MyOme test.
Review results
Reports arrive with clinical guidance, plus genetic counseling for patients.
Bring precision to every visit
We support you at every step — from ordering and sample collection to interpreting results with your patients.